Recruiting Vasculitis Studies in Lake Success
A Randomized Multicenter Study for Isolated Skin Vasculitis
Multi-center sequential multiple assignment randomized trial comparing the effectiveness of three different standard of care treatment options for patients with isolated skin vasculitis....
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
The main objective of this study is to explore the efficacy of avacopan in participants affected by AAV....
About Vasculitis Clinical Trials in Lake Success
Vasculitis refers to a group of disorders that involve inflammation of blood vessels, which can restrict blood flow and damage organs. Types include ANCA-associated vasculitis, giant cell arteritis, and Takayasu arteritis. Treatment typically involves corticosteroids and immunosuppressive medications.
There are currently 2 vasculitis clinical trials recruiting participants in Lake Success, NEW%20YORK. These studies are seeking a combined 110 participants. Research is being sponsored by University of Pennsylvania, Amgen. Clinical trial participation is free and participants receive study-related medical care at no cost.
Vasculitis Clinical Trials in Lake Success — FAQ
Are there vasculitis clinical trials in Lake Success?
Yes, there are 2 vasculitis clinical trials currently recruiting in Lake Success, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Lake Success?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lake Success research site will contact you about next steps.
Are clinical trials in Lake Success free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lake Success studies also compensate for your time and travel.
What vasculitis treatments are being tested?
The 2 active trials in Lake Success are testing new therapies including novel drugs, biologics, and treatment approaches for vasculitis.
Data updated March 2, 2026 from ClinicalTrials.gov